Scotland votes no for independence
September 19, 2014Medical Communications, Research and Development, Sales and Marketing NHS, Scotland
The United Kingdom remains united today as Scotland narrowly voted against breaking up the 307-year-old union. The ‘No, Better Together’ …
Astellas appoints comms head from Baxter
September 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris
Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …
Apple’s HealthKit plagued by bugs and delay
September 18, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, google, health kit, ios8, wearables
Apple’s new mobile software iOS8 was launched around the world yesterday but the eagerly anticipated centrepiece HealthKit app was conspicuous …
GSK melanoma drug sees quick NICE nod
September 18, 2014Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer
NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …
NICE reform put on hold – for now
September 17, 2014Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba
The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …
New managing director for PAN
September 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Jon Linscott, Pan, eric hansen
Creative comms agency PAN has appointed a new managing director in Eric Hansen who replaces the recently-departed Jon Linscott.Reporting in …
Cancer drug gains first early UK access grant
September 17, 2014Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising
A new type of cell therapy for cancer has become the first to be deemed by the UK government as …
Epic Sciences hires regulatory affairs VP
September 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing epic sciences, paul frieberg
San Diego-based cancer diagnostics firm Epic Sciences has appointed Glen Paul Freiberg as its vice president of regulatory affairs and …
Pfizer partners with MedGenesis on Parkinson’s
September 16, 2014Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
Pharma exports in UK help drive the economy
September 16, 2014Manufacturing and Production, Sales and Marketing UK, emerging markets, exports, hsbc, imports, pharma
The UK’s pharmaceutical sector is ‘an export success story’, enjoying a competitive advantage and generating a sizeable trade surplus. This …
Roche should be ‘shamed’ into lowering cancer drug price
September 16, 2014Medical Communications, Sales and Marketing Kadcyla, Margaret Connolly, Roche, Swiss, breast cancer, trastuzumab emtansine
A public petition to force Roche to lower the cost of its costly new breast cancer drug Kadcyla has been …
AstraZeneca teams up with rival Lilly for Alzheimer’s
September 16, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly
AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Gilead allows generic prices for Sovaldi
September 16, 2014Manufacturing and Production, Sales and Marketing Gilead, hep C, hepatitis C, sofosbuvir, sovaldi
Gilead will allow Indian generic drug firms to make cheap copies of its new hepatitis C pill Sovaldi in an …
No silver bullet, but a growing arsenal for pharma comms
September 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck, comms, eyeforpharma, mcm, selincro, tim white
Digital strategies in the pharma industry have predominately been a red herring, focussing too much on the novelty of digital …
Tiziana appoints Intercept head to its board
September 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roberto pelliccaiari, tiziana
UK biotech firm Tiziana Life Sciences has confirmed that Professor Roberto Pellicciari is joining its scientific advisory board and will …
UK pharma pays out £150m in drug rebates
September 12, 2014Medical Communications, Sales and Marketing ABPI, PPRS, Roche, emms, rebate
The UK pharma industry has paid £150 million back to the government as part of its rebate to “underwrite the …
FDA panel backs liraglutide for obesity
September 12, 2014Manufacturing and Production, Sales and Marketing Arena Pharmaceuticals, Belviq, Novo Nordisk, Qsymia, Victoza, Vivus, diabetes, obesity
An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …
Google’s Calico takes first steps into research
September 12, 2014Medical Communications, Sales and Marketing AbbVie, P7C3, Parkinson's, Parkinson’s, calico, depression, google, motor neurone disease
Google is finally shifting into gear within the health arena as it signs its first research deal to develop a …
Cerenis announces board chairman
September 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerenis
France and US-based biopharma firm Cerenis Therapeutics has confirmed the appointment of Dr Richard Pasternak as its chairman of the …
Lilly and Boehringer diabetes biosimilar sees EU approval
September 11, 2014Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly
Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
